
How A Coronavirus Blood Test Could Solve Some Medical Mysteries
Listen
BY RICHARD HARRIS
As the coronavirus spreads more widely around the globe, scientists are starting to use a powerful new tool: a blood test that identifies people who have previously been exposed to the virus. This kind of test is still under development in the United States, but it has been rolled out for use in Singapore and China.
The current lab test used in the United States identifies people who are currently spreading the virus that causes COVID-19. That’s crucial information, but that test doesn’t reveal who had previously been infected. That’s important too for understanding the unfolding epidemic.
The other test, used widely in science and medicine, detects antibodies that people produce after they’ve become infected with a bacterium or virus. Those antibodies can appear in the blood one to three weeks after infection, and they’re part of the immune system’s response to infection.
The antibody-based tests can identify people who were not known to be infected “either because they never developed symptoms, or they had symptoms that were never correctly diagnosed,” says Lauren Ancel Meyers, a biology professor at the University of Texas at Austin.
Related Stories:

Doctors still doing damage control after pandemic fallout
When the COVID-19 pandemic reached the Inland Northwest almost three years ago, Dr. Max Williams started seeing a change in some of his patients that shocked him: People he had treated successfully for years no longer trusted him. Continue Reading Doctors still doing damage control after pandemic fallout

Fusion reactions: Not just for your time-traveling DeLorean
The target chamber of LLNL’s National Ignition Facility, where 192 laser beams delivered more than 2 million joules of ultraviolet energy to a tiny fuel pellet to create fusion ignition… Continue Reading Fusion reactions: Not just for your time-traveling DeLorean

Some hospitals in contingency operations, pediatric units rationing drugs
Idaho’s hospitals are feeling the strain from the “tripledemic” of RSV, flu and COVID-19, officials say. Dr. Jim Souza is the chief physician executive at St. Luke’s Health System in Boise. Continue Reading Some hospitals in contingency operations, pediatric units rationing drugs